Non-invasive vs Invasive Cardiac Output Monitoring During Cesarean Section

Launched by GENERAL HOSPITAL OF NINGXIA MEDICAL UNIVERSITY · Jun 24, 2024

Keywords

ClinConnect Summary

This clinical trial is studying different methods of monitoring blood flow in women undergoing a cesarean section. Specifically, it will compare two newer technologies, NICAP and NICCO, with a traditional method called pulse wave analysis. The goal is to see how well these methods work to track blood circulation during surgery, which is important for the health of both the mother and the baby.

To participate in this study, women aged 18 to 45 who are having their first or subsequent baby and are at least 37 weeks pregnant may be eligible. They should be scheduled for a cesarean section using spinal anesthesia and must meet certain health criteria. Participants can expect to be monitored using the different technologies during their surgery, helping researchers understand which method is more effective. The trial is not yet recruiting, so it’s still in the planning stages, but it aims to improve care for mothers during cesarean deliveries.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 18-45 years
• • Primipara or multipara
• • Singleton pregnancy ≥37 weeks
• • American Society of Anesthesiologists physical status classification I to II
• • Scheduled for cesarean section under spinal anesthesia
• Exclusion Criteria:
• • Body height \< 150 cm
• • Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2
• • Eclampsia or chronic hypertension or baseline blood pressure ≥140 mmHg
• • Hemoglobin \< 7g/dl
• • Fetal distress, or known fetal developmental anomaly